Medicared For All Logo

David Cozzolino MD in Newark, Delaware

Home Delaware Newark

David Cozzolino MD has Urology as his primary medical specialty. Their primary office is: 4701 Ogletown Stanton Rd in Newark, Delaware. There is an additional office location, for a total of two, for David Cozzolino MD that can be viewed further down.

They're a part of the: Brandywine Urology Consultants Pa medical group which has around 14 members. You can call their office at 302-652-8990 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Chicago, Pritzker School Of Medicine and graduated in 1993 (around 31 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


David J Cozzolino MD Office Phone and Directions

David Cozzolino MD
Brandywine Urology Consultants Pa
4701 Ogletown Stanton Rd
Newark, Delaware 19713
302-652-8990


Patient Ratings
Please rate your experience with David Cozzolino MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 302-652-8990


Enter a starting address:


Healthcare Info for David Cozzolino MD

Medical School: University Of Chicago, Pritzker School Of Medicine
Graduation Year: 1993
The Primary Medical Specialty for David Cozzolino MD is listed as: Urology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 4183638497
NPI #: 1144278722
NPI Created On: 05/05/2006
NPI Last Updated Listed as: 07/16/2015
Primary Taxonomy Code: 208800000X
License Number:
C10006248
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Highmark BCBSD Inc.
  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • AmeriHealth HMO, Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of hormone pellets beneath the skin
  2. Shock wave crushing of kidney stones
  3. Insertion of indwelling bladder catheter
  4. Ultrasound measurement of bladder capacity after voiding
  5. Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
  6. Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope
  7. Insertion of stent in urinary duct (ureter) using an endoscope
  8. Injection procedure to correct abnormally thickened penile tissue
  9. Injection procedure to induce erection
  10. Insertion of needles or catheters into prostate for radiation therapy
  11. Automated urinalysis test
  12. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  13. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  14. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  15. New patient office or other outpatient visit, typically 30 minutes
  16. New patient office or other outpatient visit, typically 45 minutes
  17. Established patient office or other outpatient visit, typically 5 minutes
  18. Established patient office or other outpatient visit, typically 10 minutes
  19. Established patient office or other outpatient visit, typically 15 minutes
  20. Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792743011

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: HYPERHYDROSIS

Name of Drug #1: BOTOX

Open Associated Drug #1: 0023-1145-01


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794295509

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: LUPRON DEPOT

Open Associated Drug #1: 0074-3346-03


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794295511

Being Disputed:: No

Product Related: No


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 777763749

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: PAIN MANAGEMENT

Name of Drug #1: REZUM


Payments Total: $89

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833070251

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 821291585

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: UROLOGY

Name of Drug #1: MYRBETRIQ

Open Associated Drug #1: 0469-2601-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 821291589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99

Drug or Biological: Drug

Product Category #2: UROLOGY

Name Of Drug #2:: MYRBETRIQ

Associated Drug #2: 0469-2601-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 821291593

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: UROLOGY

Name of Drug #1: MYRBETRIQ

Open Associated Drug #1: 0469-2601-30


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 851425459

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER

Name of Drug #1: PROVENGE

Open Associated Drug #1: 30237-8900-6


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 789059069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Nubeqa

Open Associated Drug #1: 50419-395-01


Additional Office Locations

1. Brandywine Urology Consultants Pa
2000 Foulk Rd
Wilmington, DE 19810
Suite F
Group Members: 14

Phone: 302-652-8990

Enter a starting address:


Urology Professionals in Newark

4701 Ogletown Stanton Rd
Newark, DE
Brandywine Urology Consultants Pa

4701 Ogletown Stanton Rd
Newark, DE
Brandywine Urology Consultants Pa

4701 Ogletown Stanton Rd
Newark, DE
Brandywine Urology Consultants Pa

4701 Ogletown Stanton Rd
Newark, DE
Brandywine Urology Consultants Pa

4701 Ogletown Stanton Rd
Newark, DE
Brandywine Urology Consultants Pa

4701 Ogletown Stanton Rd
Newark, DE
Brandywine Urology Consultants Pa

Providers in Brandywine Urology Consultants Pa

1.Katherine Abernethy

4701 Ogletown Stanton Rd
Newark De 19713-2069
Brandywine Urology Consultants Pa
Nurse Practitioner

2.Katherine Abernethy

2000 Foulk Rd
Wilmington De 19810-3642
Brandywine Urology Consultants Pa
Nurse Practitioner

3.Bruce Benge Md

4701 Ogletown Stanton Rd
Newark De 19713-2069
Brandywine Urology Consultants Pa
Urology

4.Bruce Benge Md

2000 Foulk Rd
Wilmington De 19810-3642
Brandywine Urology Consultants Pa
Urology

5.David Cozzolino Md

4701 Ogletown Stanton Rd
Newark De 19713-2069
Brandywine Urology Consultants Pa
Urology

6.David Cozzolino Md

2000 Foulk Rd
Wilmington De 19810-3642
Brandywine Urology Consultants Pa
Urology

View all 14 members of Brandywine Urology Consultants Pa medical group